U.S. Sen. Claire McCaskill is putting pressure on the Trump administration to lay out exactly how it plans to reduce the price of naloxone, an overdose drug.
According to a Washington Examiner report, the Democratic senator sent a letter on Tuesday to Health and Human Services Secretary Alex Azar asking if the agency has sought from drugmakers a reason for the drug’s pricing.
McCaskill, according to the report, noted Kaleo boosted the price of a two-pack of Evzio to $4,500 in 2016 from $690 in 2014. Hospira also increased the price of its overdose treatment by 129 percent from 2012 to 2016.
“Despite the existence of patient assistance and donation programs, these price increases complicate the goal of boosting the availability of naloxone,” she wrote.
Click here to read the full report on the Washington Examiner.
